End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.77 CNY | -2.26% |
|
-4.05% | -6.47% |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Its low valuation, with P/E ratio at 10.15 and 7.62 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company is one of the best yield companies with high dividend expectations.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.47% | 1.32B | - | ||
+3.30% | 103B | A- | ||
-11.38% | 59.18B | A- | ||
+75.24% | 48.74B | B | ||
+5.45% | 34.98B | B | ||
+0.09% | 30.99B | A- | ||
+2.97% | 18.53B | B- | ||
+17.26% | 17.42B | C+ | ||
+4.48% | 13.32B | B- | ||
-8.50% | 12.47B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 002895 Stock
- Ratings Guizhou Chanhen Chemical Corporation